Patrick J. Killela

3.7k citations

14 papers · 3.0k · 3 hit papers · h-index 11

Impact in

Genetics top 0.5%
- Glioma Diagnosis and Treatment
Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation

Papers in

Genetics 8
- Glioma Diagnosis and Treatment 8
- Genetics and Neurodevelopmental Disorders 1
Cancer Research 5
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 2

Co-authors: Darell D. Bigner (5 shared papers)Roger E. McLendon (5 shared papers)Hai Yan (5 shared papers)Chunhui Di (3 shared papers)Simon G. Gregory (3 shared papers)Christopher G. Duncan (2 shared papers)William C. Chen (2 shared papers)David A. Solomon (1 shared paper)
Journals: Oncotarget (4 papers)Neuro-Oncology (2 papers)Nature Genetics (1 paper)Cancer Research (1 paper)Molecular Cancer Research (1 paper)
Partner nations: United States China Australia

In The Last Decade

Patrick J. Killela

13 papers receiving 3.0k citations

Patrick J. Killela's Hit Papers

align trajectories log scale

TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL 2014 · 470 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2014 Neuro-Oncology
2013 Proceedings of the National Academy of Sciences
2012 Oncotarget

Peers

Countries citing papers authored by Patrick J. Killela

Since Specialization

Citations

This map shows the geographic impact of Patrick J. Killela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Killela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Killela more than expected).

Fields of papers citing papers by Patrick J. Killela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Killela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Killela. The network helps show where Patrick J. Killela may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick J. Killela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick J. Killela Line = papers co-authored together Patrick J. Killela links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal Proceedings of the National Academy of Sciences ·Patrick J. Killela, Zachary J. Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis Alberto Diaz, Allan H. Friedman, Henry S. Friedman Hit paper breakdown →	2013	1159
2	Frequent ATRX , CIC , FUBP1 and IDH1 mutations refine the classification of malignant gliomas Oncotarget ·Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodríguez, Sérgio Rosemberg Hit paper breakdown →	2012	487
3	TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL Neuro-Oncology ·Hai Yan, Patrick J. Killela, Zachary J. Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Laura A. Diaz, Allan H. Friedman Hit paper breakdown →	2014	470
4	Mutations in IDH1 , IDH2 , and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas Oncotarget ·Patrick J. Killela, Christopher J. Pirozzi, Patrick N Healy, Zachary J. Reitman, Eric Lipp, B. Ahmed Rasheed, Rui Ryan Yang, Bill H. Diplas	2014	222
5	Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation European Journal of Cancer ·Dongsheng Huang, Zhaohui Wang, Xujun He, Bill H. Diplas, Rui Ryan Yang, Patrick J. Killela, Qun Meng, Zai‐yuan Ye	2015	160
6	Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas Nature Genetics ·Liwei Zhang, Lee H. Chen, Hong Wan, Rui Ryan Yang, Zhaohui Wang, Jie Feng, Shaohua Yang, Siân Jones	2014	147
7	The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma Nature Communications ·Bill H. Diplas, Xujun He, Jacqueline A. Brosnan‐Cashman, Heng Liu, Lee H. Chen, Zhaohui Wang, Casey J. Moure, Patrick J. Killela	2018	130
8	Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes Oncotarget ·Christopher G. Duncan, Patrick J. Killela, Cathy A. Payne, Benjamin L. Lampson, William C. Chen, Jeff Liu, David A. Solomon, Todd A. Waldman	2010	86
9	The genetic landscape of anaplastic astrocytoma Oncotarget ·Patrick J. Killela, Christopher J. Pirozzi, Zachary J. Reitman, Siân Jones, B. Ahmed Rasheed, Eric Lipp, Henry S. Friedman, Allan H. Friedman	2013	64
10	Glioblastoma Proto-oncogene SEC61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress Cancer Research ·Zheming Lu, Lei Ji Zhou, Patrick J. Killela, Ahmed B. Rasheed, Chunhui Di, William E. Poe, Roger E. McLendon, Darell D. Bigner	2009	59
11	Deletion or Epigenetic Silencing of AJAP1 on 1p36 in Glioblastoma Molecular Cancer Research ·Ningjing Lin, Chunhui Di, Kathy Bortoff, Jinrong Fu, Peter Truszkowski, Patrick J. Killela, Christopher G. Duncan, Roger E. McLendon	2012	35
12	HDMX regulates p53 activity and confers chemoresistance to 3-Bis(2-chloroethyl)-1-nitrosourea Neuro-Oncology ·Genglin Jin, Stephen Cook, Bo Cui, William C. Chen, Stephen Thomas Keir, Patrick J. Killela, Chunhui Di, Cathy A. Payne	2010	10
13	Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome Familial Cancer ·Shahid Mahmood Baig, Ambrin Fatima, Muhammad Tariq, Tahir Naeem Khan, Zafar Ali, Mohammad Omar Faheem, Humera Mahmood, Patrick J. Killela	2018	4
14	Mitigation of supply chain challenges in cell therapy manufacturing: perspectives from the cord blood alliance Stem Cells Translational Medicine ·Patrick J. Killela, Kieran Herrity, Ludwig Frontier, Roger B. V. Horton, Joanne Kurtzberg, Wouter Van’t Hof	2024	0

About Patrick J. Killela

Patrick J. Killela is a scholar working on Genetics, Cancer Research, Molecular Biology, Cell Biology and Physiology, having authored 14 papers that have together received 3.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (3 papers), Chromatin Remodeling and Cancer (2 papers), Microtubule and mitosis dynamics (2 papers), Renal and related cancers (2 papers), Telomeres, Telomerase, and Senescence (2 papers), MicroRNA in disease regulation (2 papers) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Genetics (1.4k citations), Cancer Research (748 citations), Physiology (595 citations), Aging (37 citations) and Molecular Biology (1.3k citations). Patrick J. Killela has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Darell D. Bigner, Roger E. McLendon, Hai Yan, Chunhui Di, Simon G. Gregory, Christopher G. Duncan, William C. Chen, David A. Solomon, Christopher V. Nicchitta and Lei Ji Zhou. Their work appears in journals such as Oncotarget, Neuro-Oncology, Nature Genetics, Cancer Research and Molecular Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Patrick J. Killela

Impact in

Papers in i

In The Last Decade

Patrick J. Killela

Patrick J. Killela's Hit Papers

Peers

Countries citing papers authored by Patrick J. Killela

Fields of papers citing papers by Patrick J. Killela

All Works

About Patrick J. Killela

Explore authors with similar magnitude of impact

Papers in